Health-Related Quality of Life and Cost-Effectiveness of First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Monotherapy in Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Systematic Review.

Tagrisso (osimertinib) - AstraZeneca

Ameile (aumolertinib) - Jiangsu Hansoh Pharma

Lazcluze (lazertinib) - J&J

Vizimpro (dacomitinib) - Pfizer

Gilotrif (afatinib) - Boehringer Ingelheim

http://www.ncbi.nlm.nih.gov/pubmed/42775053

Dharmendra Singh; Harminder Singh; Himel Mondal; Pradosh Kumar Sarangi; Seshadri Reddy Varikasuvu; Shiv K Mudgal; Subodh Kumar; Sumit Mahato

Sep 24, 2026